AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Gliminyle-M2 Tablet PR

Prescription Icon
Prescription Required

Marketer

Erinyle Pharma

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Gliminyle-M2 Tablet PR

DiaBeta-Duo tablets are classified as antidiabetic medications, combining two active agents to manage type 2 diabetes in adults. This dual-action formulation helps regulate blood glucose levels. DiaBeta-Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined individually by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with seemingly controlled blood sugar, as premature discontinuation, without medical consultation, risks elevated glucose levels and potential complications such as nephropathy, retinopathy, neuropathy, and limb loss. This medication forms one component of a comprehensive diabetes management plan, incorporating a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most frequently reported adverse effect. Learn to identify symptoms—sweating, lightheadedness, headache, tremors—and implement appropriate countermeasures. Maintain regular mealtimes and carry a readily available fast-acting glucose source (e.g., sugary sweets or juice). Alcohol consumption elevates hypoglycemia risk and should be limited. Additional possible side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur in some patients. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests (blood cell counts and liver function) are recommended by your doctor.

Uses of Gliminyle-M2 Tablet PR

Managing Type 2 diabetes

Major Benefits of Gliminyle-M2 Tablet PR:

Follow your physician's instructions or consult the product label for proper administration. Consume Gliminyle-M2 Tablet PR with a meal.

Common Side effects of Gliminyle-M2 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Gliminyle-M2 Tablet PR:

Follow your doctor's instructions or refer to the product label for dosage guidance. Always take Gliminyle-M2 Tablet PR with a meal.

How Gliminyle-M2 Tablet PR works:

Gliminyle-M2 Tablet PR combines glimepiride, a sulfonylurea, and metformin, a biguanide, to manage blood sugar. Glimepiride stimulates the pancreas to release more insulin, thus reducing blood glucose. Metformin acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol and Gliminyle-M2 Tablet PR use poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Gliminyle-M2 Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation is contraindicated with Gliminyle-M2 Tablet PR due to potential infant toxicity.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Gliminyle-M2 Tablet PR requires careful administration for individuals with impaired kidney function. Dosage modification of Gliminyle-M2 Tablet PR might be necessary; physician consultation is advised. For patients exhibiting severe kidney disease, Gliminyle-M2 Tablet PR is contraindicated. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Gliminyle-M2 Tablet PR cautiously, potentially requiring dosage modification. Consult a physician for guidance. For those with mild to moderate liver disease, a low initial dose is typically prescribed; however, its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Gliminyle-M2 Tablet PR :

Should you forget a Gliminyle-M2 Tablet PR dose, take it promptly. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Gliminyle-M2 Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Gliminyle-M2 Tablet PR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Dispose of any unused medication properly and ensure it remains inaccessible to children, pets, and others.
Gliminyle-M2 Tablet PR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but dangerous side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Gliminyle-M2 Tablet PR and seek immediate medical attention.
Gliminyle-M2 Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 DM.
Gliminyle-M2 Tablet PR may cause common side effects such as hypoglycemia (low blood sugar), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Prolonged Gliminyle-M2 Tablet PR use can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Gliminyle-M2 Tablet PR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Gliminyle-M2 Tablet PR and alcohol is unsafe. Alcohol can worsen Gliminyle-M2's blood sugar-lowering effects, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Gliminyle-M2 Tablet PR
135
MRP 165
18% off